Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children
- 1 May 1993
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 152 (5) , 389-392
- https://doi.org/10.1007/bf01955893
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Psoriasis in childhood.Archives of Disease in Childhood, 1992
- The Cytokine Network in PsoriasisArchives of Dermatology, 1991
- Cyclosporine for Plaque-Type PsoriasisNew England Journal of Medicine, 1991
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- [23] Measurement of ionized calcium in biological fluids: Ion-selective electrode methodPublished by Elsevier ,1988
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Topical administration of 1,25-dihydroxyvitamin D3 for proriasis: Report of five casesCalcified Tissue International, 1986
- Psoriasis and its treatment.BMJ, 1981